Clinical Toxicology: Vol 60, No 3

Por um escritor misterioso
Last updated 05 abril 2025
Clinical Toxicology: Vol 60, No 3
Clinical Toxicology: Vol 60, No 3
Progress in Medicinal Chemistry, Volume 60 - 1st Edition
Clinical Toxicology: Vol 60, No 3
Clinical Trial in a Dish Arteriosclerosis, Thrombosis, and Vascular Biology
Clinical Toxicology: Vol 60, No 3
Accurate clinical toxicity prediction using multi-task deep neural nets and contrastive molecular explanations
Clinical Toxicology: Vol 60, No 3
Medical Laboratory Scientist - Explore Health Care Careers - Mayo Clinic College of Medicine & Science
Clinical Toxicology: Vol 60, No 3
Ms Betty Chan
Clinical Toxicology: Vol 60, No 3
An Advanced Atlas of Histology
Clinical Toxicology: Vol 60, No 3
The evolving role of investigative toxicology in the pharmaceutical industry
Clinical Toxicology: Vol 60, No 3
Toxics, Free Full-Text
Clinical Toxicology: Vol 60, No 3
Management of poison(Emergency Medicine)
Clinical Toxicology: Vol 60, No 3
Green Toxicology: Connecting Green Chemistry and Modern Toxicology
Clinical Toxicology: Vol 60, No 3
SOTRADECOL 3% (SODIUM TETRADECYL SULFATE INJECTION) 30mg PER 2mL (30mg/mL)
Clinical Toxicology: Vol 60, No 3
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing

© 2014-2025 trend-media.tv. All rights reserved.